ProQR Therapeutics NV at Chardan Genetic Medicines Conference (Virtual) Transcript
I'd like to introduce our next guest from ProQR Therapeutics, Chief Financial Officer, Smital Shah. The format for this session is a 25-minute fireside chat. (Operator Instructions). With that, Smital, welcome. Thanks for joining us again this year.
Questions & Answers
And to start, can you please provide a couple of minutes of introductory comments about the state of the business for ProQR, summarizing your differentiated approach, and what's been achieved in 2021 year to date?
Yes, absolutely. First of all, thank you, Keay, for having us and thank you to Chardan for inviting us again to a very productive conference. I really appreciate that. I also, before I start, want to point people to our website and our forward-looking statements. Also, do take a look when you get the chance.
I think to your question on the state of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |